Albert Wong

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    Chan Juan Shen
    Translational Research Center, Zhengzhou University People s Hospital, 7 Weiwu Road, Zhengzhou, Henan 450003, China
    J Hematol Oncol 6:33. 2013
  2. pmc Development of an EGFRvIII specific recombinant antibody
    Puja Gupta
    Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA
    BMC Biotechnol 10:72. 2010
  3. ncbi request reprint Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme
    Catherine A Del Vecchio
    Stanford University, 300 Pasteur Drive, Edwards R213, Stanford, CA 94305, USA
    Curr Opin Mol Ther 12:741-54. 2010

Research Grants

  1. ALTERED EGF RECEPTORS IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2001
  2. The Role of JNK in Glial Tumor Pathogenesis
    Albert Wong; Fiscal Year: 2006
  3. NOVEL EFFECTORS OF GRB2 IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2009

Collaborators

  • Puja Gupta
  • Chan Juan Shen
  • Shuang Yin Han
  • Catherine A Del Vecchio
  • Yun Fei Wang
  • Yi Wang
  • Li ming Zhao
  • Ying Ying Zhao
  • Ethan Q Han
  • Jian Cui
  • Na Cao
  • Yu xiu Yang
  • Ryan T Nitta
  • Marina Holgado-Madruga
  • Gordon Li
  • Siddhartha S Mitra

Detail Information

Publications3

  1. pmc Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    Chan Juan Shen
    Translational Research Center, Zhengzhou University People s Hospital, 7 Weiwu Road, Zhengzhou, Henan 450003, China
    J Hematol Oncol 6:33. 2013
    ..Our current study aimed to investigate the specific and efficient antitumor effect of T cells modified with CAR containing inducible costimulator (ICOS) signaling domain...
  2. pmc Development of an EGFRvIII specific recombinant antibody
    Puja Gupta
    Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA
    BMC Biotechnol 10:72. 2010
    ..Furthermore, a monoclonal antibody to EGFRvIII is not readily available to the scientific community...
  3. ncbi request reprint Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme
    Catherine A Del Vecchio
    Stanford University, 300 Pasteur Drive, Edwards R213, Stanford, CA 94305, USA
    Curr Opin Mol Ther 12:741-54. 2010
    ..Phase I and II clinical trials in patients with GBM were ongoing at the time of publication. In the future, it may be beneficial to combine rindopepimut with other treatment modalities to further prolong survival...

Research Grants3

  1. ALTERED EGF RECEPTORS IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2001
    ..The structure of alternative transcripts from the Gab1 gene in tumors will be determined and their effects on transformation and signaling will be evaluated. ..
  2. The Role of JNK in Glial Tumor Pathogenesis
    Albert Wong; Fiscal Year: 2006
    ..This work will further enhance our knowledge of this novel signaling pathway in this human cancer and provide new avenues for diagnostics and therapeutics. ..
  3. NOVEL EFFECTORS OF GRB2 IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2009
    ..abstract_text> ..